ClinicalMetric / Countries / Austria / blastic plasmacytoid dendritic cell neoplasm bpdcn
← 🇦🇹 Austria Trials
🇦🇹 Austria Country × Condition

blastic plasmacytoid dendritic cell neoplasm bpdcn Clinical Trials in Austria

Active clinical trials for blastic plasmacytoid dendritic cell neoplasm bpdcn with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇦🇹 Austria

Active Trials in Austria (1)

NCT07785154
Recruiting

A Registry-study of ELZONRIS in Participants With BPDCN

Enrollment
80 pts
Country
🇦🇹 Austria
Stemline Therapeutics, Inc.
View Trial →

Frequently Asked Questions

How many blastic plasmacytoid dendritic cell neoplasm bpdcn clinical trials are active in Austria?
There are currently 1 active clinical trials for blastic plasmacytoid dendritic cell neoplasm bpdcn with sites in Austria, of which 1 are actively recruiting patients.
How can I join a blastic plasmacytoid dendritic cell neoplasm bpdcn clinical trial in Austria?
To join a blastic plasmacytoid dendritic cell neoplasm bpdcn clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are blastic plasmacytoid dendritic cell neoplasm bpdcn trials in Austria?
Active blastic plasmacytoid dendritic cell neoplasm bpdcn trials in Austria span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Austria Trials → Global blastic plasmacytoid dendritic cell neoplasm bpdcn Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology